Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 22Active not recruiting 11Not yet recruiting 9Completed 6Withdrawn 2Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 6Glioblastoma 6Colorectal Neoplasms 6Breast Neoplasms 6Neoplasm Metastasis 5Prostatic Neoplasms 4Pancreatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Multiple Myeloma 3Leukemia, Myeloid, Acute 3Glioma 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Solid Tumors 2Solid Tumor 2Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Osteosarcoma 2Melanoma 2Lymphoma, T-Cell 2Lung Neoplasms 2Immunoblastic Lymphadenopathy 2Carcinoma, Renal Cell 2Carcinoma 2Brain Neoplasms 2Biliary Tract Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lymphoma, B-Cell × 30 days × Clear all
NCT06662227 2026-05-07

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

Wondercel Biotech (ShenZhen)

Phase EARLY_PHASE1 Suspended
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡